SIS Requests Suspension of Ohio Board of Pharmacy Compounding Rules

News & Press: Advocacy

Monday, July 18, 2016

SIS joins 17 local, state, and national medical associations in sending a letter to the Ohio Board of Pharmacy (BOP) requesting an indefinite suspension of the compounding rules until after the USP Chapter <797> updates are finalized.

« Back to Index

Latest News more

10/15/2025What IPSIS is Doing For You: October 2025

10/14/2025Seeking PNS Policy Revisions From BCBS

10/13/2025ACT NOW: Save Peripheral Nerve Block and RFA Coverage

10/9/2025IPSIS Seeks Physician Waiver From New $100K Visa Fee

10/8/2025BVNRFN: Find the Facts

Calendar more

11/8/2025 » 11/9/2025
Lumbar Bio-Skills Lab - New Orleans, Louisiana - SOLD OUT

11/8/2025 » 11/9/2025
Cervical Bio-Skills Lab - New Orleans, Louisiana - SOLD OUT

11/8/2025 » 11/9/2025
Radiofrequency Bio-Skills Lab - New Orleans, Louisiana - SOLD OUT

2/26/2026 » 2/28/2026
IPSIS 2026 Winter Seminar - San Juan, Puerto Rico

3/28/2026 » 3/29/2026
Lumbar, Radiofrequency, or Disc and Vertebral Body Access Bio-Skills Labs - Las Vegas, Nevada

4/25/2026 » 4/26/2026
IPSIS 2026 European Congress - Budapest, Hungary

	Edit This Favorite
Name:
Category:
Share:	Yes No, Keep Private

Edit This Favorite

SIS Requests Suspension of Ohio Board of Pharmacy Compounding Rules

Contact Us